Sonus Pharmaceuticals

Sonus Pharmaceuticals, Inc. is a drug reformulation company focused on the optimization of therapeutic drugs to treat cancer and other serious diseases. The Company is developing a number of potential product candidates utilizing its TOCOSOL drug delivery technology. The TOCOSOL technology platform, designed to address the formulation challenges of therapeutic drugs, uses vitamin E oil (tocopherol) and tocopherol derivatives to solubilize and stabilize drugs for formulation enhancement, and is particularly suited to injectable drugs that are poorly soluble in water. The Company's lead product, TOCOSOL Paclitaxel, is a formulation of paclitaxel, a prescribed anti-cancer drugs. TOCOSOL Paclitaxel is a ready-to-use injectable paclitaxel emulsion.

Previous Forums
Date/Time		Forum
Nov 13 2001		Virtual Drug Delivery Stocks Forum
Jul 27 2001		San Francisco Biotechnology Stocks Forum
Feb 13 2001		Virtual Pharmaceutical Stocks Forum
Dec 9 2000		Fourth Seattle Cancer Stocks Forum
Nov 18 2000		Third Bay Area Drug Delivery Stocks Forum
Jan 15 2000		BioSpace.com Bay Area Biotechnology Stocks Forum

Market Assistant		PrecisionAlert
Earnings Data Annual Report		Enter your email address to receive alerts about this company